The data on (NASDAQ:BLUE) Bluebird bios main pipeline seems lacking in results. The stock has rallied on optimism. It is time to SELL.
I expect this stock to take a huge downturn with the next upside coming in mid to late fall.
Sell Bluebird bio.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.